Neurotrope Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
1.30
6.30
6.90
3.90
3
Gross Income
-
1.30
6.30
6.90
3.90
3
SG&A Expense
6,859.70
9,265.80
9,439.50
12,925.70
12,698.10
11,146.40
EBIT
6,859.70
9,267.10
9,445.80
12,932.60
12,702.00
11,149.40
Unusual Expense
731.10
-
-
-
53.60
-
Non Operating Income/Expense
-
-
-
-
34.30
-
Pretax Income
7,589.40
9,253.30
9,441.50
12,924.20
12,615.10
11,022.30
Consolidated Net Income
7,589.40
9,253.30
9,441.50
12,924.20
12,615.10
11,022.30
Net Income
7,589.40
9,253.30
9,441.50
12,924.20
12,615.10
11,022.30
Net Income After Extraordinaries
7,589.40
9,253.30
9,441.50
12,924.20
12,615.10
11,022.30
Net Income Available to Common
7,589.40
10,917.50
9,721.40
12,924.20
12,615.10
11,022.30
EPS (Basic)
11.19
15.80
11.52
5.69
1.64
1.37
Basic Shares Outstanding
678.20
690.80
835.20
2,272.00
7,709.40
8,050.70
EPS (Diluted)
11.19
15.80
11.64
5.69
1.64
1.37
Diluted Shares Outstanding
678.20
690.80
835.20
2,272.00
7,709.40
8,050.70
EBITDA
6,859.70
9,265.80
9,439.50
12,925.70
12,698.20
11,146.40
Non-Operating Interest Income
1.40
13.80
4.20
8.40
67.60
127.10
Preferred Dividends
-
1,664.20
279.80
-
-
-
About Neurotrope
View Profile
